Back to BBIO
Aisling Capital Management LP → BBIO
Aisling Capital Management LP BBIO Position History
BridgeBio Pharma, Inc. • Healthcare
Quarters held
4
Latest value
$203.3M
Q3 2026
Peak value
$389.3M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $389.3M |
| Q1 2026 | $378M |
| Q2 2026 | $341.8M |
| Q3 2026 | $203.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $203.3M | 3.09M | — | — |
| Q2 2026 | $341.8M | 4.59M | — | — |
| Q1 2026 | $378M | 5.09M | — | — |
| Q4 2025 | $389.3M | 5.09M | — | — |
Other funds holding BBIO
$950.9M
$950.9M
Other Aisling Capital Management LP positions
MNST
$37.6MMONTE ROSA THERAPEUTICS INC
SNDX
$30.8MSyndax Pharmaceuticals, Inc. (SNDX)
SNDX
$28.8MSYNDAX PHARMACEUTICALS INC
SNDX
$27.7MSyndax Pharmaceuticals, Inc. (SNDX)
MNST
$25.6MMonte Rosa Therapeutics Inc (GLUE)
SNDX
$24.8MSYNDAX PHARMACEUTICALS INC
MNST
$23.1MMonte Rosa Therapeutics Inc (GLUE)
CMPS
$21.6MCOMPASS PATHWAYS PLC